Literature DB >> 11037958

A comparison of nurse and patient perceptions of chemotherapy treatment stressors.

F A Parsaie1, M Golchin, I Asvadi.   

Abstract

To assess how closely nurses and patients considered various situations as causing stress in chemotherapy treatment, this study was designed to compare nurse and patient perceptions of chemotherapy treatment stressors for patients in an oncology hospital. This descriptive study was conducted in the summer of 1997. Fifty patients receiving cytotoxic treatment were chosen by random sample. All 21 registered nurses of the Tabriz University of Medical Sciences who worked in the oncology department were contacted. A Likert-type questionnaire was designed to measure the stressfulness of commonly occurring items in chemotherapy treatment. The intensity of each item was measured by a scale with response choices ranging from the most to the least important. The patients were asked to indicate their perceptions of the seriousness of stress by sorting items. The nurses were asked to complete the same questionnaire as the patients completed. The greatest physical stressor mentioned by the patients was fatigue (66%), and by nurses, alopecia (62%). The nurses' perceptions of psychosocial items causing the greatest stress included fear of disease recurrence (90.5%), fear of death (90.5%), economic problems (90.5%), and appearance changes (90.5%), whereas the patients perceived dependency (80%), economic problems (70%), and loss of social activity (66%), as the greatest stressors (p < 0.05). The findings showed disagreement between the two groups on intensity of physical and psychosocial stressors (p < 0.05). The results from this study increased nurses' awareness of important stress factors in chemotherapy treatment. Identification of the situations perceived to be more stressful than others helped clinical nurses to modify their care and provide for their patients in a way that removes or reduces the stressors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11037958     DOI: 10.1097/00002820-200010000-00008

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  6 in total

Review 1.  Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies.

Authors:  Sébastien Simard; Belinda Thewes; Gerry Humphris; Mélanie Dixon; Ceara Hayden; Shab Mireskandari; Gozde Ozakinci
Journal:  J Cancer Surviv       Date:  2013-03-10       Impact factor: 4.442

2.  Measuring clinical benefit: use of patient-reported outcomes (PRO) in primary brain tumor clinical trials.

Authors:  Terri S Armstrong
Journal:  Curr Oncol Rep       Date:  2013-02       Impact factor: 5.075

3.  Meeting information needs on cancer-related fatigue: an exploration of views held by Italian patients and nurses.

Authors:  Michela Piredda; Maria Grazia De Marinis; Laura Rocci; Raffaella Gualandi; Daniela Tartaglini; Emma Ream
Journal:  Support Care Cancer       Date:  2007-03-21       Impact factor: 3.603

4.  Analysis of differences in subjective health status according to characteristics of hospitalized cancer patients.

Authors:  Ji-Youn Kim; Eun-Surk Yi
Journal:  J Exerc Rehabil       Date:  2018-10-31

5.  The psychosocial needs of underserved breast cancer survivors and perspectives of their clinicians and support providers.

Authors:  Kristen J Wells; Julia H Drizin; Amy E Ustjanauskas; Coralia Vázquez-Otero; Tonya M Pan-Weisz; Danielle Ung; Claudia Carrizosa; Christine Laronga; Richard G Roetzheim; Kenneth Johnson; Marilyn Norton; Rosa Cobian Aguilar; Gwendolyn P Quinn
Journal:  Support Care Cancer       Date:  2021-07-07       Impact factor: 3.603

6.  Developing theory-informed knowledge translation strategies to facilitate the use of patient-reported outcome measures in interdisciplinary low back pain clinical practices in Quebec: mixed methods study.

Authors:  Owis Eilayyan; Regina Visca; Diana Zidarov; Patrick Ware; André Bussières; Sara Ahmed
Journal:  BMC Health Serv Res       Date:  2020-08-25       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.